AKTS
Price
$19.90
Change
-$1.00 (-4.78%)
Updated
Feb 4, 04:59 PM (EDT)
Capitalization
1.09B
Intraday BUY SELL Signals
ERIXF
Price
$11.00
Change
+$2.70 (+32.53%)
Updated
Feb 3 closing price
Capitalization
36.6B
Intraday BUY SELL Signals
Interact to see
Advertisement

AKTS vs ERIXF

Header iconAKTS vs ERIXF Comparison
Open Charts AKTS vs ERIXFBanner chart's image
Aktis Oncology
Price$19.90
Change-$1.00 (-4.78%)
Volume$23.55K
Capitalization1.09B
Ericsson (L.M.) Telephone
Price$11.00
Change+$2.70 (+32.53%)
Volume$2.09K
Capitalization36.6B
AKTS vs ERIXF Comparison Chart in %
ERIXF
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
AKTS vs. ERIXF commentary
Feb 05, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AKTS is a StrongBuy and ERIXF is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Feb 05, 2026
Stock price -- (AKTS: $20.90 vs. ERIXF: $11.00)
Brand notoriety: AKTS and ERIXF are both not notable
AKTS represents the Biotechnology, while ERIXF is part of the Telecommunications Equipment industry
Current volume relative to the 65-day Moving Average: AKTS: 61% vs. ERIXF: 2%
Market capitalization -- AKTS: $1.09B vs. ERIXF: $36.6B
AKTS [@Biotechnology] is valued at $1.09B. ERIXF’s [@Telecommunications Equipment] market capitalization is $36.6B. The market cap for tickers in the [@Biotechnology] industry ranges from $118.13B to $0. The market cap for tickers in the [@Telecommunications Equipment] industry ranges from $328.38B to $0. The average market capitalization across the [@Biotechnology] industry is $2.23B. The average market capitalization across the [@Telecommunications Equipment] industry is $10.22B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

AKTS’s FA Score shows that 0 FA rating(s) are green whileERIXF’s FA Score has 1 green FA rating(s).

  • AKTS’s FA Score: 0 green, 5 red.
  • ERIXF’s FA Score: 1 green, 4 red.
According to our system of comparison, ERIXF is a better buy in the long-term than AKTS.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ERIXF’s TA Score shows that 5 TA indicator(s) are bullish.

  • ERIXF’s TA Score: 5 bullish, 4 bearish.

Price Growth

AKTS (@Biotechnology) experienced а -1.51% price change this week, while ERIXF (@Telecommunications Equipment) price change was +1.95% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -2.56%. For the same industry, the average monthly price growth was +1.40%, and the average quarterly price growth was +33.10%.

The average weekly price growth across all stocks in the @Telecommunications Equipment industry was -0.98%. For the same industry, the average monthly price growth was +7.12%, and the average quarterly price growth was +32.78%.

Industries' Descriptions

@Biotechnology (-2.56% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

@Telecommunications Equipment (-0.98% weekly)

The Telecommunications Equipment industry produces voice and data communications equipment, which includes fiber optic delivery products, digital signal processors, high-speed voice, data and video delivery. Additionally, satellite systems, global positioning systems, wireless data systems, personal communications equipment, telephone handsets and payload equipment for satellites also fall into this category. Apple Inc., QUALCOMM Incorporated and Nokia are major global players in this segment.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ERIXF($36.6B) has a higher market cap than AKTS($1.09B).
AKTSERIXFAKTS / ERIXF
Capitalization1.09B36.6B3%
EBITDAN/A37.7B-
Gain YTDN/A15.003-
P/E RatioN/A11.59-
RevenueN/A240B-
Total CashN/A52.3B-
Total DebtN/A43.9B-
FUNDAMENTALS RATINGS
AKTS vs ERIXF: Fundamental Ratings
AKTS
ERIXF
OUTLOOK RATING
1..100
6888
VALUATION
overvalued / fair valued / undervalued
1..100
42
Fair valued
8
Undervalued
PROFIT vs RISK RATING
1..100
59100
SMR RATING
1..100
10036
PRICE GROWTH RATING
1..100
3442
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
n/an/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

ERIXF's Valuation (8) in the null industry is somewhat better than the same rating for AKTS (42) in the Telecommunications Equipment industry. This means that ERIXF’s stock grew somewhat faster than AKTS’s over the last 12 months.

AKTS's Profit vs Risk Rating (59) in the Telecommunications Equipment industry is somewhat better than the same rating for ERIXF (100) in the null industry. This means that AKTS’s stock grew somewhat faster than ERIXF’s over the last 12 months.

ERIXF's SMR Rating (36) in the null industry is somewhat better than the same rating for AKTS (100) in the Telecommunications Equipment industry. This means that ERIXF’s stock grew somewhat faster than AKTS’s over the last 12 months.

AKTS's Price Growth Rating (34) in the Telecommunications Equipment industry is in the same range as ERIXF (42) in the null industry. This means that AKTS’s stock grew similarly to ERIXF’s over the last 12 months.

AKTS's P/E Growth Rating (100) in the Telecommunications Equipment industry is in the same range as ERIXF (100) in the null industry. This means that AKTS’s stock grew similarly to ERIXF’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ERIXF
RSI
ODDS (%)
Bearish Trend 2 days ago
62%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
64%
Momentum
ODDS (%)
Bullish Trend 2 days ago
57%
MACD
ODDS (%)
Bullish Trend 2 days ago
57%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
56%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
52%
Advances
ODDS (%)
N/A
Declines
ODDS (%)
Bearish Trend 14 days ago
59%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
61%
Aroon
ODDS (%)
Bullish Trend 2 days ago
45%
View a ticker or compare two or three
Interact to see
Advertisement
ERIXF
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
CRYPTO / NAMEPrice $Chg $Chg %
IMX.X0.1813640.003416
+1.92%
Immutable cryptocurrency
ELF.X0.083061-0.000952
-1.13%
aelf cryptocurrency
VIC.X0.062808-0.001915
-2.96%
Viction cryptocurrency
AERGO.X0.053254-0.001982
-3.59%
Aergo cryptocurrency
MC.X0.017703-0.001458
-7.61%
Merit Circle cryptocurrency

AKTS and

Correlation & Price change

A.I.dvisor indicates that over the last year, AKTS has been loosely correlated with CGON. These tickers have moved in lockstep 34% of the time. This A.I.-generated data suggests there is some statistical probability that if AKTS jumps, then CGON could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To AKTS
1D Price
Change %
AKTS100%
-4.91%
CGON - AKTS
34%
Loosely correlated
-3.28%
NBY - AKTS
33%
Loosely correlated
-32.16%
ZNTL - AKTS
27%
Poorly correlated
+12.35%
SPRY - AKTS
27%
Poorly correlated
-1.46%
CRDO - AKTS
24%
Poorly correlated
-7.21%
More

ERIXF and

Correlation & Price change

A.I.dvisor indicates that over the last year, ERIXF has been loosely correlated with ERIC. These tickers have moved in lockstep 40% of the time. This A.I.-generated data suggests there is some statistical probability that if ERIXF jumps, then ERIC could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ERIXF
1D Price
Change %
ERIXF100%
+1.95%
ERIC - ERIXF
40%
Loosely correlated
+1.55%
AKTS - ERIXF
23%
Poorly correlated
-4.91%
NOK - ERIXF
20%
Poorly correlated
+0.99%
FKWL - ERIXF
13%
Poorly correlated
N/A
MFCO - ERIXF
2%
Poorly correlated
-0.79%
More